Funding Details
- Awarder
- Inbox
- Date Award
- March 19, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$65,000,000
Company Info
- Traction
- The company announced the advancement of two lead programs and a second discovery partnership in obesity.
- Company Description
- Ampersand Biomedicines is a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else.
- Market
- Pharmaceuticals
- Location
-
Boston,
MA,
USA
- Coinvestors
- Flagship Pioneering, Eli Lilly & Company
Links